EXAMINING THE ROLE OF LEPTIN SIGNALING IN A PATIENT-DERIVED MODEL OF TRIPLE NEGATIVE BREAST CANCER

被引：0
|
作者：
Brock, C. [1 ]
Wright, M. [1 ]
Nguyen, K. [1 ]
Cheng, T. [1 ]
Collins-Burow, B. [1 ]
Bunnell, B. [2 ]
Burow, M. [1 ]
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA USA
[2] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2022年 / 70卷 / 02期
关键词：
D O I：
10.1136/jim-2022-SRMC.452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
448
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [31] Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models
    Guo, Zhanfang
    Luo, Jingqin
    Mashl, R. Jay
    Hoog, Jeremy
    Maiti, Piyush
    Fettig, Nikki
    Davies, Sherri R.
    Aft, Rebecca
    Held, Jason M.
    Govindan, Ramaswamy
    Ding, Li
    Li, Shunqiang
    von Morze, Cornelius
    Wulf, Gerburg M.
    Shoghi, Kooresh I.
    Ma, Cynthia X.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (06): : 1430 - 1440
  • [32] Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
    D. Merino
    T. S. Weber
    A. Serrano
    F. Vaillant
    K. Liu
    B. Pal
    L. Di Stefano
    J. Schreuder
    D. Lin
    Y. Chen
    M. L. Asselin-Labat
    T. N. Schumacher
    D. Cameron
    G. K. Smyth
    A. T. Papenfuss
    G. J. Lindeman
    J. E. Visvader
    S. H. Naik
    Nature Communications, 10
  • [33] Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
    Merino, D.
    Weber, T. S.
    Serrano, A.
    Vaillant, F.
    Liu, K.
    Pal, B.
    Di Stefano, L.
    Schreuder, J.
    Lin, D.
    Chen, Y.
    Asselin-Labat, M. L.
    Schumacher, T. N.
    Cameron, D.
    Smyth, G. K.
    Papenfuss, A. T.
    Lindeman, G. J.
    Visvader, J. E.
    Naik, S. H.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [34] Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer
    Wang, Xiaoqiang
    Petrossian, Karineh
    Huang, Miao-Juei
    Saeki, Kohei
    Kanaya, Noriko
    Chang, Gregory
    Somlo, George
    Chen, Shiuan
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 206
  • [35] A clinically relevant prognostic mRNA signature for triple-negative breast cancer developed from the patient-derived xenograft model
    Moon, Hyeong-Gon
    Oh, Keunhee
    Lee, Dong-Sup
    Han, Wonshik
    Noh, Dong-Young
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [36] Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics
    Bhatia, Sonam
    Kramer, Melissa
    Russo, Suzanne
    Naik, Payal
    Arun, Gayatri
    Brophy, Kyle
    Andrews, Peter
    Fan, Cheng
    Perou, Charles M.
    Preall, Jonathan
    Ha, Taehoon
    Plenker, Dennis
    Tuveson, David A.
    Rishi, Arvind
    Wilkinson, John E.
    McCombie, W. Richard
    Kostroff, Karen
    Spector, David L.
    CANCER RESEARCH, 2022, 82 (07) : 1174 - 1192
  • [37] Early activation of IFN/STAT signaling in tumor cells of patient-derived triple negative breast cancer xenografts predicts tumor sensitivity to chemotherapy
    Legrier, M-E
    Yvonnet, V.
    Beurdeley, A.
    Stephant, G.
    Le, Ven E.
    Banis, S.
    Lassalle, M.
    Deas, O.
    Cairo, S.
    Judde, J-G
    CANCER RESEARCH, 2012, 72
  • [38] Dinaciclib overcomes resistance to BKM120 in triple negative breast cancer patient-derived xenograft models
    Rajput, Sandeep
    Guo, Fang
    Shun, Li
    Ma, Cynthia
    CANCER RESEARCH, 2017, 77
  • [39] Utilizing decellularized triple-negative breast cancer patient-derived tumor models as drug testing platforms
    Wright, Maryl
    Khoa Nguyen
    Martin, Elizabeth
    Bratton, Melyssa
    Collins-Burow, Bridgette
    Burow, Matthew
    CANCER RESEARCH, 2022, 82 (12)
  • [40] The adaptive resistome in triple-negative breast cancer: Functional targeting in patient-derived organoids and cell lines
    Classen, S.
    Rahlf, E.
    Goerte, J.
    Parplys, A. C.
    Schumacher, U.
    Petersen, C.
    Rothkamm, K.
    Toulany, M.
    Cordes, N.
    Borgmann, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S195 - S195
12345